WO2011085367A3 - Non-replicating microorganisms as post-biotics - Google Patents

Non-replicating microorganisms as post-biotics Download PDF

Info

Publication number
WO2011085367A3
WO2011085367A3 PCT/US2011/020826 US2011020826W WO2011085367A3 WO 2011085367 A3 WO2011085367 A3 WO 2011085367A3 US 2011020826 W US2011020826 W US 2011020826W WO 2011085367 A3 WO2011085367 A3 WO 2011085367A3
Authority
WO
WIPO (PCT)
Prior art keywords
post
biotics
replicating microorganisms
replicating
microorganisms
Prior art date
Application number
PCT/US2011/020826
Other languages
French (fr)
Other versions
WO2011085367A2 (en
Inventor
Jeffrey Daniel Hillman
Original Assignee
Oragenics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oragenics, Inc. filed Critical Oragenics, Inc.
Publication of WO2011085367A2 publication Critical patent/WO2011085367A2/en
Publication of WO2011085367A3 publication Critical patent/WO2011085367A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Abstract

The invention provides non-replicating, post-biotic microorganisms for the safe prevention or treatment of diseases, infections, colonizations, biofilm conditions, and biofouling conditions.
PCT/US2011/020826 2010-01-11 2011-01-11 Non-replicating microorganisms as post-biotics WO2011085367A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29388410P 2010-01-11 2010-01-11
US61/293,884 2010-01-11

Publications (2)

Publication Number Publication Date
WO2011085367A2 WO2011085367A2 (en) 2011-07-14
WO2011085367A3 true WO2011085367A3 (en) 2011-09-01

Family

ID=44306191

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/020826 WO2011085367A2 (en) 2010-01-11 2011-01-11 Non-replicating microorganisms as post-biotics

Country Status (1)

Country Link
WO (1) WO2011085367A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002045727A1 (en) * 2000-12-08 2002-06-13 Plbio Co., Ltd. Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa
US20040166094A1 (en) * 2000-06-09 2004-08-26 Darouiche Rabih O. Combination of antimicrobial agents and bacterial interference to coat medical devices

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040166094A1 (en) * 2000-06-09 2004-08-26 Darouiche Rabih O. Combination of antimicrobial agents and bacterial interference to coat medical devices
WO2002045727A1 (en) * 2000-12-08 2002-06-13 Plbio Co., Ltd. Lactic acid bacteria inhibiting adhesion of helicobacter pylori to gastric mucosa

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOLES ET AL.: "agr-Mediated Dispersal of Staphylococcus aureus Biofilms", PLOS PATHOGENS, vol. 4, no. 4, 2008, pages 1 - 13 *
FUERST ET AL.: "Inactivation of Bacteria by Decay of Incorporated Radioactive Phosphorus", J GEN PHYSIOL, vol. 40, no. 1, 1956, pages 73 - 90 *
PARK ET AL.: "Infection Control by Antibody Disruption of Bacterial Quorum Sensing Signaling", CHEMISTRY & BIOLOGY, vol. 14, 2007, pages 1119 - 1127 *
RUBIN ET AL.: "Growth and mutation of bacteria during continuous irradiation", J BACTERIOL, vol. 67, no. 3, 1954, pages 361 - 368 *

Also Published As

Publication number Publication date
WO2011085367A2 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
IL213489A0 (en) Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces
HK1225961A1 (en) Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
WO2010062396A3 (en) Virus like particle compositions and methods of use
EP3474861A4 (en) Compositions comprising hmos, their production and use for the prevention and/or treatment of viral and/or bacterial infections
WO2012112777A3 (en) Biosynthesis of human milk oligosaccharides in engineered bacteria
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
WO2014052836A3 (en) Methods and compositions for treating infection
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
WO2012020214A3 (en) Anti-microbial metal organic framework
ZA201101814B (en) Prevention, treatment and diagnosis of p.gingivalis infection
WO2012170807A3 (en) Anti-pseudomonas psl binding molecules and uses thereof
EP2651439A4 (en) Compositions and methods for the treatment or prevention of human adenovirus-36 infection
WO2011047320A3 (en) Antimicrobial compounds and methods of making and using the same
HK1248535A1 (en) Treatment or prevention of infection
WO2012017321A3 (en) Treatment for dyslipidemia
WO2011009890A3 (en) Use of azabicycloalkyl derivatives or pyrrolidine - 2 - one derivatives for the treatment or prevention of ataxia
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
WO2012048115A3 (en) Polypeptides and their use in treating and limiting respiratory syncytial virus infection
WO2011029536A3 (en) Use of cyclic keto-enols for combating plant pathogenic bacteria
WO2010123599A3 (en) Anti-bacterial compositions and methods including targeting virulence factors of staphylococcus aureus
EP2538963B8 (en) Method of treatment or prevention of hair loss or for the enhancement of hair growth
WO2011023540A3 (en) Use of cycloaliphatic diols as biocides
WO2011056486A3 (en) Devices, methods, and composition for controlling infections
WO2010105191A3 (en) Antimicrobial compositions and methods of use therefore
WO2010046461A3 (en) Treatment of intracellular bacterial infections

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11732314

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11732314

Country of ref document: EP

Kind code of ref document: A2